Differential effect of T-type voltage-gated Ca2+ channel disruption on renal plasma flow and glomerular filtration rate in vivo

American Journal of Physiology - Renal Physiology

Volumn 307, Issue 4, 2014, Pages

  Thuesen, Anne D ^a   Andersen, Henrik ^a   Cardel, Majken ^a   Toft, Anja ^b   Walter, Steen ^b   Marcussen, Niels ^b   Jensen, Boye L ^a   Bie, Peter ^a   Hansen, Pernille B L ^a  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^b ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Afferent arteriole; Efferent arteriole; Kidney arteries

Indexed keywords

4 AMINOHIPPURIC ACID; CALCIUM CHANNEL CAV3.1; CALCIUM CHANNEL CAV3.2; CALCIUM CHANNEL T TYPE; INULIN; UNCLASSIFIED DRUG; VOLTAGE GATED CALCIUM CHANNEL;

4 AMINOHIPPURIC ACID CLEARANCE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERIOLE; ARTERY CONSTRICTION; ARTICLE; BLOOD PRESSURE MEASUREMENT; CONCENTRATION RESPONSE; CONTROLLED STUDY; DEPOLARIZATION; FEMALE; GLOMERULUS FILTRATION RATE; HEART RATE; IN VIVO STUDY; INULIN CLEARANCE; KIDNEY FUNCTION; KIDNEY PLASMA FLOW; KIDNEY VASCULAR RESISTANCE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

AFFERENT ARTERIOLE; EFFERENT ARTERIOLE; KIDNEY ARTERIES;

ANIMALS; ARTERIOLES; CALCIUM CHANNELS, T-TYPE; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; INULIN; MALE; MICE; MICE, KNOCKOUT; P-AMINOHIPPURIC ACID; RENAL CIRCULATION; RENAL PLASMA FLOW; VASCULAR RESISTANCE; VASOCONSTRICTION; VASODILATION;

EID: 84906054909     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00016.2014     Document Type: Article

References (43)

1. 2+ channels in rat cerebral arteries: role in myogenic tone development. Am J Physiol Heart Circ Physiol 304: H58-H71, 2013.
2. 2 adenosine receptors dilates cortical efferent arterioles in mouse. Kidney Int 58: 793-799, 2009.
3. 2A receptors. Acta Physiol (Oxf) 203: 197-207, 2011.
4. Arima S, Ito S, Omata K, Tsunoda K, Yaoita H, Abe K. Diverse effects of calcium antagonists on glomerular hemodynamics. Kidney Int Suppl 55: S132-S134, 1996.
5. 2+ channel. Acta Physiol (Oxf) 207: 709-720, 2013.
6. 2+] in renal arterioles. Am J Physiol Renal Fluid Electrolyte Physiol 265: F677-F685, 1993.
7. Chen CC, Fan YP, Shin HS, Su CK. Basal sympathetic activity generated in neonatal mouse brainstem-spinal cord preparation requires T-type calcium channel subunit 1H. Exp Physiol 96: 486-494, 2011.
8. 2+ channels. Science 302: 1416-1418, 2003.
9. +. Am J Physiol Renal Physiol 276: F674-F683, 1999.
10. 2+ channel is required for pressure overload-induced cardiac hypertrophy in mice. Circ Res 104: 522-530, 2009.
11. Dilley JR, Stier CT Jr, Arendshorst WJ. Abnormalities in glomerular function in rats developing spontaneous hypertension. Am J Physiol Renal Fluid Electrolyte Physiol 246: F12-F20, 1984.
12. Feng MG, Li M, Navar LG. T-type calcium channels in the regulation of afferent and efferent arterioles in rats. Am J Physiol Renal Physiol 286: F331-F337, 2004.
13. Gabel RA, Ranaei RA, Kivlighn SD. A new method of measuring renal function in conscious rats without the use of radioisotopes. J Pharmacol Toxicol Methods 36: 189-197, 1996.
14. Gordienko DV, Clausen C, Goligorsky MS. Ionic currents and endothelin signaling in smooth muscle cells from rat renal resistance arteries. Am J Physiol Renal Fluid Electrolyte Physiol 266: F325-F341, 1994.
15. Hansen PB. Functional and pharmacological consequences of the distribution of voltage-gated calcium channels in the renal blood vessels. Acta Physiol (Oxf) 207: 690-699, 2013.
16. Hansen PB, Hristovska A, Wolff H, Vanhoutte P, Jensen BL, Bie P. Uridine adenosine tetraphosphate affects contractility of mouse aorta and decreases blood pressure in conscious rats and mice. Acta Physiol (Oxf) 200: 171-179, 2010.
17. Hansen PB, Jensen BL, Andreasen D, Skott O. Differential expression of T-and L-type voltage-dependent calcium channels in renal resistance vessels. Circ Res 89: 630-638, 2001.
18. Hansen PB, Poulsen CB, Walter S, Marcussen N, Cribbs LL, Skott O, Jensen BL. Functional importance of L-and P/Q-type voltage-gated calcium channels in human renal vasculature. Hypertension 58: 464-470, 2011.
19. Harada K, Nomura M, Nishikado A, Uehara K, Nakaya Y, Ito S. Clinical efficacy of efonidipine hydrochloride, a T-type calcium channel inhibitor, on sympathetic activities. Circ J 67: 139-145, 2003.
20. Hayashi K, Nagahama T, Oka K, Epstein M, Saruta T. Disparate effects of calcium antagonists on renal microcirculation. Hypertens Res 19: 31-36, 1996.
21. Hayashi K, Ozawa Y, Wakino S, Kanda T, Homma K, Takamatsu I, Tatematsu S, Saruta T. Cellular mechanism for mibefradil-induced vasodilation of renal microcirculation: studies in the isolated perfused hydronephrotic kidney. J Cardiovasc Pharmacol 42: 697-702, 2003.
22. 2+ channel subtypes and pharmacology in the kidney. Circ Res 100: 342-353, 2007.
23. Honda M, Hayashi K, Matsuda H, Kubota E, Tokuyama H, Okubo K, Takamatsu I, Ozawa Y, Saruta T. Divergent renal vasodilator action of L-and T-type calcium antagonists in vivo. J Hypertens 19: 2031-2037, 2001.
24. 2+ from intracellular stores. Hypertension 29: 222-227, 1997.
25. 3 nanoparticles do not affect kidney function but cause acute effect on the cardiovascular function in healthy mice. Toxicol Appl Pharmacol 266: 276-288, 2013.
26. Kuo IY, Ellis A, Seymour VA, Sandow SL, Hill CE. Dihydropyridineinsensitive calcium currents contribute to function of small cerebral arteries. J Cereb Blood Flow Metab 30: 1226-1239, 2010.
27. 1G-subunit of T-type calcium channels. Proc Natl Acad Sci USA 101: 18195-18199, 2004.
28. 2+ entry. Circ Res 87: 551-557, 2000.
29. Loutzenhiser R, Hayashi K, Epstein M. Divergent effects of KClinduced depolarization on afferent and efferent arterioles. Am J Physiol Renal Fluid Electrolyte Physiol 257: F561-F564, 1989.
30. 1G T-type calcium channels. Circ Res 98: 1422-1430, 2006.
31. Navar LG, Inscho EW, Imig JD, Mitchell KD. Heterogeneous activation mechanisms in the renal microvasculature. Kidney Int Suppl 67: S17-S21, 1998.
32. Ohishi M, Takagi T, Ito N, Terai M, Tatara Y, Hayashi N, Shiota A, Katsuya T, Rakugi H, Ogihara T. Renal-protective effect of T-and L-type calcium channel blockers in hypertensive patients: an Amlodipineto-Benidipine Changeover (ABC) study. Hypertens Res 30: 797-806, 2007.
33. Ohta M, Sugawara S, Sato N, Kuriyama C, Hoshino C, Kikuchi A. Effects of benidipine, a long-acting T-type calcium channel blocker, on home blood pressure and renal function in patients with essential hypertension: a retrospective, "real-world" comparison with amlodipine. Clin Drug Invest 29: 739-746, 2009.
34. 2+ channels with efonidipine decreased plasma aldosterone concentration in healthy volunteers. Hypertens Res 29: 493-497, 2006.
35. Ozawa Y, Hayashi K, Nagahama T, Fujiwara K, Saruta T. Effect of T-type selective calcium antagonist on renal microcirculation: studies in the isolated perfused hydronephrotic kidney. Hypertension 38: 343-347, 2001.
36. Poulsen CB, Al-Mashhadi RH, Cribbs LL, Skott O, Hansen PB. T-type voltage-gated calcium channels regulate the tone of mouse efferent arterioles. Kidney Int 79, 443-51, 2011.
37. Rossier MF, Ertel EA, Vallotton MB, Capponi AM. Inhibitory action of mibefradil on calcium signaling and aldosterone synthesis in bovine adrenal glomerulosa cells. J Pharmacol Exp Ther 287: 824-831, 1998.
38. Sasaki H, Saiki A, Endo K, Ban N, Yamaguchi T, Kawana H, Nagayama D, Ohhira M, Oyama T, Miyashita Y, Shirai K. Protective effects of efonidipine, a T-and L-type calcium channel blocker, on renal function and arterial stiffness in type 2 diabetic patients with hypertension and nephropathy. J Atheroscler Thromb 16: 568-575, 2009.
39. Skov K, Mulvany MJ, Korsgaard N. Morphology of renal afferent arterioles in spontaneously hypertensive rats. Hypertension 20: 821-827, 1992.
40. 2+ current. Cardiovasc Res 97: 293-301, 2013.
41. Tomino Y. Renoprotective effects of the L-/T-type calcium channel blocker benidipine in patients with hypertension. Curr Hypertens Rev 9: 108-114, 2013.
42. Yamamoto T, Hayashi K, Matsuda H, Kubota E, Tanaka H, Ogasawara Y, Nakamoto H, Suzuki H, Saruta T, Kajiya F. In vivo visualization of angiotensin II-and tubuloglomerular feedback-mediated renal vasoconstriction. Kidney Int 60: 364-369, 2001.
43. Yokoyama T, Masuda Y, Sakai T, Tanaka S, Tomita K. Effects of NZ-105, a new calcium antagonist, on renal function in anesthetized spontaneously hypertensive rats. J Cardiovasc Pharmacol 19: 851-856, 1992.